Bangalee, A, et al. “MEDICINE AND THE LAW: Dolutegravir As First-Line Antiretroviral Therapy in South Africa: Beware the One-Size-Fits-All Approach”. South African Medical Journal, vol. 112, no. 10, Oct. 2022, pp. 787-90, https://doi.org/10.7196/SAMJ.2022.v112i10.16596.